Autogenous vaccination for the treatment of therapy-resistant bacterial infections;Autogene vakzination bei therapie-resistenten bekteriellen infektionen

Chemotherapie Journal

Volumn 18, Issue 1, 2009, Pages 18-23

  Nolte, Oliver ^a,b  

^a Medizinisches Labor Brunner ^*

^b Labor Dr Brunner Konstanz   (Germany)

Author keywords

Autogenous vaccine; Autovaccine; Immune modulation; Therapeutic vaccine; Therapy refractory inlections

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; INACTIVATED VACCINE; TRICHOMONIASIS VACCINE; UNCLASSIFIED DRUG; UNIVACCIN; UROVAXOM;

AUTOGENOUS VACCINATION; BACTERIAL INFECTION; BACTERIUM CULTURE; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; REVIEW; VACCINATION;

EID: 60749112925     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Alisky J, Iczkowski K, Rapoport A, Troitsky N. Bacteriophages show promise as antimicrobial agents. J Infect 1998;36:5-15.
2. Allen RW. Die Vakzintherapie. Ihre Theorie und praktische Anwendung. Nach der vierten Auflage des Originals. Dresden und Leipzig: Verlag von Theodor Steinkopff, 1914.
3. Bindewald A. Untersuchungen zur Autovakzination bei bakteriellen Infektionskrankheiten des Menschen. Heidelberg: Dissertation Medizinische Fakultät der Universität 2001.
4. Boloczko S, Bladowski K. Autovaccine used in comprehensive treatment of staphylococcal inflammation of bone. Medycyna Doswiadczalna I Mikrobiologia (Warszawa) 1994;46:51-7.
5. Casadevall A. The third age of antimicrobial therapy. Clin Infect Dis 2006;42:1414-6.
6. De Vito D, Mastrorillo G, Rizzo G. Trattamento con autovaccino delle osteomieliti croniche. Igiene Moderna 2002;118:267-74.
7. De Vito D, Rizzo G. Il ritorno di una pratica trascurata: la terapia con autovaccini. Igiene Moderna 1999;112:1245-51.
8. Flaxman D, Griffiths P. Is tea tree oil effective at eradicating MRSA colonization? A review. Br J Community Nurs 2005;10:123-6.
9. Fleming A, Petrie GF. Recent advances in vaccine and serum therapy. Philadelphia: P. Blakiston's Son & Co. Inc., 1934.
10. Gorski A, Weber-Dabrowska B. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci 2005;62:511-9.
11. Halcon L, Milkus K. Staphylococcus aureus and wounds: a review of tea tree oil as a promising antimicrobial. Am J Infect Control 2004;32:402-8.
12. Huff WE, Huff GR, Rath NC, Balog JM, et al. Alternatives to antibiotics: utilization of bacteriophage to treat colibacillosis and prevent foodborne pathogens. Poult Sci 2005;84:655-9.
13. Kresken M, Hafner D, Schmitz F-J, Wichelhaus TA. PEG-Resistenzstudie 2004 - Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. www.p-e-g.org 2004.
14. Lee JC. Capsule and vaccine development. In: Honeyman AL, Friedman H, Bendinelli M (editors). Staphylococcus aureus infection and disease. New York: Kluwer Academic/Plenum Publishers, 2001:39-47.
15. McGowan JE Jr. Resistance in non-fermenting Gram-negative bacteria: Multidrug resistance to the maximum. Am J Med 2006:119:S29-36.
16. Nolte O. Autovaccine - Ein Überblick. Mikrobiologe 2001;11:11-6.
17. Nolte O, Haag H, Zimmermann A, Geiss HK. Staphylococcus aureus positive for the Panton-Valentine Leukocidin genes but methicillin susceptible in patients with furunculosis. Eur J Clin Microbiol Infect Dis 2005;24:477-9.
18. Okrasinska-Cholewa B. Clinical evaluation of treating accessory nasal sinus disease in children using autovaccine. Med Dosw Mikrobiol (Warszawa) 1994;46:67-73.
19. Reiter H. Vaccinetherapie und Vaccinediagnostik. Stuttgart: Verlag von Ferdinand Enke, 1913.
20. Rizzo C, Brancaccio G, De Vito D, Rizzo G. Efficacy of autovaccination therapy on post-coronary artery bypass grafting methicillin-resistant Staphylococcus aureus mediastinitis. Interact Cardiovasc Thorac Surg 2007;6:228-9.
21. Rubisz-Brzezinska J, Wilk-Czyz R, Brzezinska-Wcislo L, Kasprowicz A. [Clinical evaluation of serious forms of acne treated with autovaccine.] Med Dosw Mikrobiol (Warszawa) 1994;46:5-9.
22. Rusch V, Ottendorfer D, Zimmermann K, Gebauer F, et al. Results of an open, non-placebo controlled pilot study investigating the immuno modulatory potential of autovaccine. Arzneimittelforschung 2001;51:690-7.
23. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-62.
24. Sologub W. [Experience in using an autovaccine in treating patients with chronic osteomyelitis.] Lik Sprava 1992;11:122-5.
25. Thrull RH. Parodontitis marginalis und kardiovaskuläre Erkrankungen: Autovakzine-Therapie. Dtsch Ärztebl 2000;97:A-323/B-273/C-255.
26. Thrull RH, Lott R. Bedrohliche Zunahme Methicillin-resistenter Staphylococcus-aureus-Stämme: Nebenwirkungsfreie Immunisierung. Dtsch Ärztebl 2005;102:A-1069.
27. Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M. European regulatory conundrum of phage therapy. Future Microbiol 2007;2:485-91.
28. Weiss H-E, Nolte O, Bracknies S, Pfefferle T, et al. Autovakzine (autogene Vakzination) in der Behandlung von Pferdekrankheiten am Beispiel der Metritis. Tierärztliche Umschau 2007;62:659-66.
29. Wright AE. On therapeutic inoculations of bacterial vaccines, and their practical exploitation in the treatment of disease. Br Med J 1903;1069-74.
30. Zachrisson O, Colque-Navarro P, Gottfries CG, Regland B, et al. Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement. Eur J Clin Microbiol Infectious Dis 2004;23:98-105.